Our Science – Kummar Website
Shivaani Kummar, M.D.
Selected Publications |
1)
Hwang K, Scripture CD, Gutierrez M, Kummar S, Figg WD, Sparreboom A. Determination of the heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin in plasma by liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 830: 35-40, 2006. [Journal] |
2)
Kummar S, Gutierrez M, Doroshow JH, Murgo AJ. Drug development in oncology: classical cytotoxics and molecularly targeted agents. British journal of clinical pharmacology. 62: 15-26, 2006. [Journal] |
3)
Conley BA, Wright JJ, Kummar S. Targeting epigenetic abnormalities with histone deacetylase inhibitors. Cancer. 107: 832-40, 2006. [Journal] |
4)
Murren J, Modiano M, Kummar S, Clairmont C, Egorin M, Chu E, Sznol M. A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer. Investigational new drugs. 23: 123-35, 2005. [Journal] |
5)
Sportès C, McCarthy NJ, Hakim F, Steinberg SM, Liewehr DJ, Weng D, Kummar S, Gea-Banacloche J, Chow CK, Dean RM, Castro KM, Marchigiani D, Bishop MR, Fowler DH, Gress RE. Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients. Biol. Blood Marrow Transplant. 11: 472-83, 2005. [Journal] |
6)
O'Mahony D, Kummar S, Gutierrez ME. Non-small-cell lung cancer vaccine therapy: a concise review. J. Clin. Oncol. 23: 9022-8, 2005. [Journal] |
7)
Noronha V, Shafi NQ, Obando JA, Kummar S. Primary non-Hodgkin's lymphoma of the liver. Crit. Rev. Oncol. Hematol. 53: 199-207, 2005. [Journal] |
8)
Kummar S, Shafi NQ. False elevations in prostate-specific antigen levels affecting patient management. Clinical advances in hematology & oncology : H&O. 2: 599-601, 2004. [Journal] |
9)
Hobdy EM, Shafi NQ, Kummar S. Prostate cancer metastasis to supraclavicular lymph node. Clinical advances in hematology & oncology : H&O. 2: 223-4, 2004. [Journal] |
10)
Kummar S, Shafi NQ. Metastatic hepatocellular carcinoma. Clinical oncology (Royal College of Radiologists (Great Britain)). 15: 288-94, 2003. [Journal] |
11)
Farrell MP, Kummar S. Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer. Clinical colorectal cancer. 2: 253-6, 2003. [Journal] |
12)
Hobdy EM, Ciesielski TE, Kummar S. Unusual sites of colorectal cancer metastasis. Clinical colorectal cancer. 3: 54-7, 2003. [Journal] |
13)
Kummar S, Fogarasi M, Canova A, Mota A, Ciesielski T. Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br. J. Cancer. 86: 1884-7, 2002. [Journal] |
14)
Kummar S, Ciesielski TE, Fogarasi MC. Management of small bowel adenocarcinoma. Oncology (Williston Park, N.Y.). 16: 1364-9; discussion 1370, 1372-3, 2002. [Journal] |
15)
Kummar S, Ciesielski TE. Cytokeratin staining for primary and metastatic colorectal cancer. Clinical colorectal cancer. 1: 187-8, 2001. [Journal] |
16)
Kummar S, Ishii A, Yang HK, Venzon DJ, Kim SJ, Gress RE. Modulation of graft-versus-tumor effects in a murine allogeneic bone marrow transplantation model by tumor-derived transforming growth factor-betaI. Biol. Blood Marrow Transplant. 7: 25-30, 2001. [Journal] |
17)
Fogarasi MC, Zelkowitz RS, Messana SA, Arrighi JA, Seibyl JP, Kummar S. Positron emission tomography for the evaluation of patients with colorectal cancer. Clinical colorectal cancer. 1: 117-20, 2001. [Journal] |
18)
Kummar S, Kim SL, Halkar RK, Galt JR. In-111 labeled octreotide imaging of a primary carcinoid lesion undetected by conventional imaging studies in a patient with. Clinical nuclear medicine. 21: 634-7, 1996. [Journal] |
19)
Donovan EA, Kummar S. Targeting VEGF in cancer therapy. Current problems in cancer. 30: 7-32, , ,. [Journal] |
This page was last updated on 10/25/2006.